MAPT and myelodysplastic syndrome: In late disease stages, Mecp2 Dup showed reduced performance and motor coordination on the rotarod test, consistent with the impairment of motor skills reported in patients with MDS (Ta et al., 2022) as well as in the Tau-Mecp2 mouse model (Na et al., 2012).